- ICH GCP
- US Clinical Trials Registry
- Researchers
- Australia
- Leukemia, Lymphoid
Medical specialists from Australia tagged as investigators in clinical trials studying Leukemia, Lymphoid
Total 36 results
-
Allison BarracloughSeen in:
- Murdoch, Fiona Stanley Hospital
- Western Australia, Murdoch, Fiona Stanley Hospital
Trials:- NCT04332822 (Principal Investigator)
- NCT04965493 (Principal Investigator)
-
Anish PuliyayilSeen in:
- Albury, Border Medical Oncology Research Unit
- New South Wales, Albury, Border Medical Oncology
Trials:- NCT04332822 (Principal Investigator)
- NCT04965493 (Principal Investigator)
-
Anna JohnstonSeen in:
- Hobart, Royal Hobart Hospital
- South Australia, Adelaide, Royal Adelaide Hospital
- Tasmania, Hobart, Royal Hobart Hospital
Trials:- NCT04332822 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Anthony SchwarerSeen in:
- Victoria, Box Hill, Box Hill Hospital
Trials:- NCT03589326 (Principal Investigator)
-
Bhavna PadhyeSeen in:
- New South Wales, Hunter Regional Mail Centre, John Hunter Children's Hospital
- New South Wales, Randwick, Sydney Children's Hospital
- New South Wales, Westmead, The Children's Hospital at Westmead
Trials:- NCT04759586 (Principal Investigator)
- NCT04238819 (Principal Investigator)
- NCT05457556 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT05235165 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT00772200 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Relapsed Solid Tumor;
- Refractory Solid Tumor;
- Acute Myeloid Leukemia;
- Acute Lymphoblastic Leukemia;
- Myelodysplastic Syndrome;
- Mixed Phenotype Acute Leukemia;
- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- T Acute Lymphoblastic Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Embryonal Rhabdomyosarcoma;
- Fusion-Negative Alveolar Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Choriocarcinoma;
- Embryonal Carcinoma;
- Mixed Germ Cell Tumor;
- Central Nervous System Nongerminomatous Germ Cell Tumor;
- Immature Teratoma;
- Malignant Teratoma;
- Pineal Region Germ Cell Tumor;
- Pineal Region Immature Teratoma;
- Pineal Region Yolk Sac Tumor;
- Suprasellar Germ Cell Tumor;
- Osteosarcoma;
- Metastatic Osteosarcoma;
- Metastatic Malignant Neoplasm in the Lung;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Juvenile Myelomonocytic Leukemia;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy;
- Alveolar Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Childhood Malignant Neoplasm
-
Christopher FraserSeen in:
- Queensland, South Brisbane, Queensland Childrens Hospital
Trials:- NCT04501614 (Principal Investigator)
-
Christopher J. FraserSeen in:
- Queensland, South Brisbane, Queensland Children's Hospital
Trials:- NCT05286801 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT05359237 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03959085 (Principal Investigator)
Conditions:- Malignant Solid Neoplasm;
- Rhabdoid Tumor;
- Refractory Malignant Solid Neoplasm;
- Recurrent Malignant Solid Neoplasm;
- Recurrent Rhabdoid Tumor;
- Refractory Rhabdoid Tumor;
- Epithelioid Sarcoma;
- Kidney Medullary Carcinoma;
- Atypical Teratoid/Rhabdoid Tumor;
- Poorly Differentiated Chordoma;
- Recurrent Atypical Teratoid/Rhabdoid Tumor;
- Recurrent Chordoma;
- Recurrent Epithelioid Sarcoma;
- Recurrent Kidney Medullary Carcinoma;
- Refractory Atypical Teratoid/Rhabdoid Tumor;
- Refractory Chordoma;
- Refractory Epithelioid Sarcoma;
- Refractory Kidney Medullary Carcinoma;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Hematopoietic and Lymphoid Cell Neoplasm;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Central Nervous System Leukemia;
- Testicular Leukemia
-
Constantine TamSeen in:
- Victoria, Melbourne, The Alfred Hospital
Trials:- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
David HughesSeen in:
- Victoria, Parkville, Royal Children's Hospital Melbourne - PIN
Trials:- NCT04501614 (Principal Investigator)
-
David Ziegler, MDSeen in:
- New South Wales, Randwick, Sydney Children's Hospital
- New South Wales, Sydney, Kids Cancer Centre
- New South Wales, Sydney, Sydney Children's Hospital, Kids Cancer Center
Trials:- NCT05500508 (Principal Investigator)
- NCT04773782 (Principal Investigator)
- NCT02879643 (Principal Investigator)
Conditions:- Melanoma;
- Cervical Cancer;
- Cancer;
- Breast Cancer;
- Head and Neck Cancer;
- Gastric Cancer;
- Colorectal Cancer;
- Esophageal Cancer;
- Solid Tumor;
- Endometrial Cancer;
- Advanced Cancer;
- Diffuse Midline Glioma, H3 K27M-Mutant;
- Papillary Thyroid Cancer;
- Solid Carcinoma;
- Mesotheliomas Pleural;
- Glioma, Malignant;
- Ovary Cancer;
- DIPG Brain Tumor;
- Nsclc;
- Mesothelioma Peritoneum;
- CNS Tumor;
- Solid Tumor, Unspecified, Child;
- Relapsed Solid Neoplasm;
- Lymphoblastic Leukemia, Acute, Childhood;
- ALL, Childhood;
- Lymphoblastic Leukemia, Acute
-
Diane HannaSeen in:
- Victoria, Parkville, Royal Children's Hospital
Trials:- NCT03914625 (Principal Investigator)
- NCT03817398 (Principal Investigator)
-
Draga BarbaricSeen in:
- New South Wales, Randwick, Sydney Children's Hospital
Trials:- NCT03794349 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT02176967 (Principal Investigator)
Conditions:- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Acute Lymphoblastic Leukemia;
- B Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Neuroblastoma;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Ganglioneuroblastoma
-
Elizabeth L. HeskethSeen in:
- New South Wales, Hunter Regional Mail Centre, John Hunter Children's Hospital
- New South Wales, Newcastle, John Hunter Children's Hospital
Trials:- NCT02724579 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04994132 (Principal Investigator)
Conditions:- Medulloblastoma;
- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Acute Lymphoblastic Leukemia;
- B Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Alveolar Rhabdomyosarcoma;
- Embryonal Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma
-
Emma VernerSeen in:
- Concord, Concord Repatriation General Hospital
- New South Wales, Concord, Concord Repatriation General Hospital
Trials:- NCT04332822 (Principal Investigator)
- NCT04965493 (Principal Investigator)
-
Francoise Mechinaud, MDSeen in:
- Victoria, Parkville,, Royal Children's Hospital, Melbourne
Trials:- NCT02879643 (Principal Investigator)
-
Gaurav SutraveSeen in:
- New South Wales, Wentworthville, Westmead Hospital
Trials:- NCT04666038 (Principal Investigator)
- NCT05023980 (Principal Investigator)
Conditions: -
Gavin CullSeen in:
- Western Australia, Nedlands, Sir Charles Gairdner Hospital
Trials:- NCT04965493 (Principal Investigator)
Conditions: -
Joanna CzerwinskiSeen in:
- South Australia, Adelaide, Flinders Medical Centre
Trials:- NCT04965493 (Principal Investigator)
Conditions: -
Kristy McCarthySeen in:
- New South Wales, Hunter Regional Mail Centre, John Hunter Children's Hospital
Trials:- NCT04759586 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03959085 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Mixed Phenotype Acute Leukemia
-
Maria L. KirbySeen in:
- South Australia, North Adelaide, Women's and Children's Hospital-Adelaide
Trials:- NCT02724579 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT00082745 (Principal Investigator)
Conditions:- Medulloblastoma;
- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Regional Neuroblastoma;
- Stage 4S Neuroblastoma;
- Ganglioneuroblastoma;
- Stage 4 Neuroblastoma;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Mixed Phenotype Acute Leukemia;
- Childhood Malignant Neoplasm
-
Marianne B. PhillipsSeen in:
- Western Australia, Perth, Perth Children's Hospital
Trials:- NCT04320888 (Principal Investigator)
- NCT04759586 (Principal Investigator)
- NCT03155620 (Principal Investigator)
- NCT02724579 (Principal Investigator)
- NCT04195555 (Principal Investigator)
- NCT01790152 (Principal Investigator)
- NCT03213652 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT05099003 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT05235165 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT00772200 (Principal Investigator)
- NCT00082745 (Principal Investigator)
Conditions:- Refractory Lymphoma;
- Refractory Malignant Solid Neoplasm;
- Recurrent Ependymoma;
- Recurrent Ewing Sarcoma;
- Recurrent Hepatoblastoma;
- Recurrent Histiocytic and Dendritic Cell Neoplasm;
- Recurrent Langerhans Cell Histiocytosis;
- Recurrent Lymphoma;
- Recurrent Malignant Germ Cell Tumor;
- Recurrent Malignant Glioma;
- Recurrent Malignant Solid Neoplasm;
- Recurrent Medulloblastoma;
- Recurrent Neuroblastoma;
- Recurrent Non-Hodgkin Lymphoma;
- Recurrent Osteosarcoma;
- Recurrent Peripheral Primitive Neuroectodermal Tumor;
- Recurrent Rhabdoid Tumor;
- Recurrent Rhabdomyosarcoma;
- Recurrent Soft Tissue Sarcoma;
- Recurrent WHO Grade 2 Glioma;
- Refractory Ependymoma;
- Refractory Ewing Sarcoma;
- Refractory Hepatoblastoma;
- Refractory Histiocytic and Dendritic Cell Neoplasm;
- Refractory Langerhans Cell Histiocytosis;
- Refractory Malignant Germ Cell Tumor;
- Refractory Malignant Glioma;
- Refractory Medulloblastoma;
- Refractory Neuroblastoma;
- Refractory Non-Hodgkin Lymphoma;
- Refractory Osteosarcoma;
- Refractory Peripheral Primitive Neuroectodermal Tumor;
- Refractory Rhabdoid Tumor;
- Refractory Rhabdomyosarcoma;
- Refractory Soft Tissue Sarcoma;
- Refractory WHO Grade 2 Glioma;
- Wilms Tumor;
- Hematopoietic and Lymphatic System Neoplasm;
- Primary Mediastinal Large B-Cell Lymphoma;
- Malignant Glioma;
- Rhabdoid Tumor;
- Advanced Malignant Solid Neoplasm;
- Langerhans Cell Histiocytosis;
- Recurrent Glioma;
- Ann Arbor Stage III Non-Hodgkin Lymphoma;
- Ann Arbor Stage IV Non-Hodgkin Lymphoma;
- Histiocytic Sarcoma;
- Juvenile Xanthogranuloma;
- Recurrent Childhood Rhabdomyosarcoma;
- Recurrent Primary Central Nervous System Neoplasm;
- Refractory Glioma;
- Refractory Primary Central Nervous System Neoplasm;
- Stage III Osteosarcoma AJCC v7;
- Stage III Soft Tissue Sarcoma AJCC v7;
- Stage IV Osteosarcoma AJCC v7;
- Stage IV Soft Tissue Sarcoma AJCC v7;
- Stage IVA Osteosarcoma AJCC v7;
- Stage IVB Osteosarcoma AJCC v7;
- Medulloblastoma;
- Osteosarcoma;
- Lymphoblastic Lymphoma;
- Recurrent Malignant Neoplasm;
- Hodgkin Lymphoma in Remission;
- Leukemia in Remission;
- Recurrent Leukemia;
- Malignant Solid Neoplasm;
- Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;
- Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;
- High Risk Neuroblastoma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Glioblastoma;
- Anaplastic Astrocytoma;
- Anaplastic Astrocytoma, Not Otherwise Specified;
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant;
- Glioblastoma, Not Otherwise Specified;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Embryonal Rhabdomyosarcoma;
- Fusion-Negative Alveolar Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Choriocarcinoma;
- Embryonal Carcinoma;
- Mixed Germ Cell Tumor;
- Central Nervous System Nongerminomatous Germ Cell Tumor;
- Immature Teratoma;
- Malignant Teratoma;
- Pineal Region Germ Cell Tumor;
- Pineal Region Immature Teratoma;
- Pineal Region Yolk Sac Tumor;
- Suprasellar Germ Cell Tumor;
- Metastatic Osteosarcoma;
- Metastatic Malignant Neoplasm in the Lung;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Acute Myeloid Leukemia;
- Juvenile Myelomonocytic Leukemia;
- Myelodysplastic Syndrome;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Neuroblastoma;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Ganglioneuroblastoma;
- Regional Neuroblastoma;
- Stage 4S Neuroblastoma;
- Stage 4 Neuroblastoma;
- Alveolar Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Childhood Malignant Neoplasm
-
Marianne PhillipsSeen in:
- Western Australia, Nedlands, Perth Childrens Hospital
Trials:- NCT04501614 (Principal Investigator)
-
Mark PolizzottoSeen in:
- Australian Capital Territory, Garran, Canberra Hospital
Trials:- NCT04666038 (Principal Investigator)
Conditions: -
Masa LasicaSeen in:
- Melbourne, St. Vincent Hospital
- Victoria, Fitzroy, St. Vincent's Hospital
Trials:- NCT04260217 (Principal Investigator)
- NCT04965493 (Principal Investigator)
-
Matthew GreenwoodSeen in:
- New South Wales, Saint Leonards, Royal North Shore Hospital
Trials:- NCT03589326 (Principal Investigator)
-
Michelle MartinSeen in:
- Victoria, Clayton, Monash Medical Center-Clayton Campus
Trials:- NCT03914625 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT03959085 (Principal Investigator)
Conditions:- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Mixed Phenotype Acute Leukemia
-
Orly LaveeSeen in:
- New South Wales, Darlinghurst, St Vincent's Hospital
Trials:- NCT04666038 (Principal Investigator)
Conditions: -
Pasquale FedeleSeen in:
- Victoria, Clayton, Monash Medical Centre
Trials:- NCT03589326 (Principal Investigator)
-
Patricia WalkerSeen in:
- Victoria, Frankston, Peninsula Private Hospital
Trials:- NCT04965493 (Principal Investigator)
- NCT05023980 (Principal Investigator)
- NCT06088654 (Principal Investigator)
-
Peter Thian Guan TanSeen in:
- Western Australia, Nedlands, One Clinical Research
- Western Australia, Perth, Royal Perth Hospital
Trials:- NCT04662255 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT05254743 (Principal Investigator)
Clinical Trials on Leukemia, Lymphoid
-
University Hospital, BrestRecruitingChronic Lymphoid LeukaemiaFrance
-
University Hospital, LilleAssistance Publique - Hôpitaux de Paris; Hospices Civils de Lyon; Central Hospital... and other collaboratorsCompletedAcute Lymphoid Leukemia Relapse | Acute Lymphoid Leukemia Relapse After Bone Marrow TransplantFrance
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyActive, not recruitingAdvanced Lymphoid LeukemiaUnited States, United Kingdom, Japan, France, Spain
-
Institut Paoli-CalmettesAix Marseille UniversitéUnknownLeukemia, Myeloid, Acute | Acute Lymphoid LeukemiaFrance
-
Great Ormond Street Hospital for Children NHS Foundation...Medical Research Council; UCL Great Ormond Street Institute of Child HealthRecruitingRelapsed/Refractory T-cell Acute Lymphoid LeukaemiaUnited Kingdom
-
French Innovative Leukemia OrganisationRecruiting
-
University of PennsylvaniaChildren's Hospital of PhiladelphiaActive, not recruitingAcute Lymphoid LeukemiaUnited States
-
University Hospital, ToursRecruitingAcute Lymphoid Leukemia | Acute Myeloid Leukemia in ChildrenFrance
-
Cancer Institute and Hospital, Chinese Academy...CompletedAcute Lymphoid LeukemiaChina
-
Dana-Farber Cancer InstituteAcetylon Pharmaceuticals IncorporatedActive, not recruitingRecurrent Chronic Lymphoid LeukemiaUnited States